Note: Descriptions are shown in the official language in which they were submitted.
WO 2022/233624
PCT/EP2022/060870
1
HYDRATABLE CONCENTRATED SURFACTANT COMPOSITION SUBSTANTIALLY FREE
OF ISETHIONATES
Field of the Invention
The present invention is directed to a hydratable concentrated surfactant
composition. The
composition is pourable, substantially free of sulfate and oil, comprises a C6
-C14 acid, amide,
alcohol or mixture thereof, anionic surfactant, and an amphoteric surfactant,
zwitterionic
surfactant or both. The hydratable concentrated surfactant composition further
comprises a
structuring agent and the anionic surfactant comprises less than 0.0075% by
weight isethionate.
Background of the Invention
Liquid based cleansing compositions, such as shampoos and body washes, are
common and
enjoyed by many consumers. Such compositions typically have water as the
predominant
ingredient, and they are often sold in plastic bottles or tubes. The
compositions are
conventionally formulated to have a viscosity that is customary for consumer
use and easy for
evacuation from the package they are sold in.
It is often publicized that the world's oceans will soon have more plastic
than fish. Given
environmental concerns and the desire for consumers and conscious companies to
do more for
the planet, there is a strong desire to use less plastic when selling
products, including consumer
products. In view of this, efforts have been made to sell product in
concentrate form, and
therefore, ship product that comprises less water. The difficulty with
concentrates is consumers
often do not like adding additional water to the concentrate and further work,
like stirring and
shaking, to transform the concentrate into an end usable product. As to the
hydrated product,
common complaints include that the product is not homogeneous after adding
water and/or of
undesirable viscosity.
It is of increasing interest to develop a concentrate that is easy to pour and
hydrate, results in a
consumer product that is ready to use in under five (5) minutes and of very
desirable
characteristics, including viscosity. It is also desirable to develop a
concentrate that is
substantially free of sulfate and that is easy to use with a refill package to
reduce plastic waste.
This invention, therefore, is directed to a hydratable concentrated
composition that comprises a
C6 -C14 acid, amide, alcohol or mixture thereof, anionic surfactant, and an
amphoteric surfactant,
zwitterionic surfactant or both. The composition further comprises a
structuring agent and the
CA 03215163 2023- 10- 11
WO 2022/233624
PCT/EP2022/060870
2
anionic surfactant comprises less than 0.0075% by weight isethionate. The
composition is in
lamellar phase, and unexpectedly, thickens and transforms to an isotropic
phase upon dilution.
The composition can be used as a concentrate that is diluted as needed or can
be diluted with
water in refill packaging to ensure a reduction in plastic waste. Furthermore,
the composition of
the present invention can be formulated at low pH to better accommodate acidic
actives.
Additional information
Efforts have been disclosed for making wash compositions. In U.S. patent
application
publication 2019/0314258 Al, rheofluidifying concentrated foaming compositions
are described.
Further efforts have been disclosed for making wash compositions. In
W02019/074992A1 and
W02019/074993A1, sulfate free personal cleansing compositions with low
inorganic salt are
described.
Even other efforts have been disclosed for making wash compositions. In U.S.
patent
application publication 2018/098923 Al, personal care compositions
substantially free of
sulfated surfactants are described.
Still other efforts have been disclosed for making wash compositions. In U.S.
patent application
2019/282480 Al, self-thickening cleansing compositions with N-acyl acidic
amino acids or salts
thereof and an amphoteric surfactant are described.
None of the additional information describes surfactant containing
compositions as described
and claimed in the present invention.
Summary of the Invention
In a first aspect, the present invention is directed to a hydratable
concentrated surfactant
composition having a viscosity from 25 to 10,000 cps (preferably from 25 to
7,500 cps, more
preferably, from 250 to 3,500 cps) wherein the composition thickens and
increases in viscosity
when diluted with water at a composition to water weight ratio from 1:1 to
1:10 (preferably 1:1 to
1:7, more preferably 1:1.5 to 1:6, most preferably 1:1.75 to 1:3) to produce
an end use composition
having a viscosity from 1,000 to 20,000 cps (preferably 2,000 to 15,000 cps,
even more preferably,
3,000 to 12,000 cps, and most preferably, 5,000 to 9,000 cps), the composition
comprises from 1
to 30% by weight anionic surfactant wherein less than 0.0075% by weight of the
anionic surfactant
is isethionate.
CA 03215163 2023- 10- 11
WO 2022/233624
PCT/EP2022/060870
3
In a second aspect, the present invention is directed to the hydratable
concentrated surfactant
composition of the first aspect of the invention wherein the composition
comprises a structurant and
transforms from lamellar to isotropic form (i.e., microstructure) upon
dilution.
In a third aspect, the present invention is directed to the hydratable
concentrated surfactant
composition having a viscosity from 25 to 10,000 cps wherein the composition
is suitable to be
diluted with water at a composition to water weight ratio from 1:1 to 1:10 to
produce an end use
composition having a viscosity from 1,000 to 20,000 cps and further wherein
the hydratable
composition comprises:
a) an anionic surfactant comprising less than 0.0075% by weight acyl
isethionate;
b) an amphoteric and/or zwitterionic surfactant;
c) a C6-C14 acid, amide and/or alcohol;
d) from 30 to 85% by weight water; and
e) structuring agent,
the end use composition having a viscosity that is greater than the viscosity
of the hydratable
concentrated surfactant composition.
In a fourth aspect, the invention is directed to a hydratable concentrated
surfactant composition
comprising:
a) an anionic surfactant comprising less than 0.0075% by weight isethionate;
b) an amphoteric and/or zwitterionic surfactant;
c) a C6 -C14 acid, amide and/or alcohol;
d) from 30 to 85% by weight water; and
f) structuring agent
wherein the structuring agent comprises an ethoxylated fatty acid ester.
In a fifth aspect, the invention is directed to an end use composition made by
diluting at least one
of the hydratable concentrated surfactant compositions of the first four
aspects of the invention
wherein the end use composition produced has a viscosity that is greater than
the viscosity of the
hydratable concentrated surfactant composition it is prepared from.
In a sixth aspect, the invention is directed to the use of the end use
composition of the fifth aspect
of the invention to cosmetically treat skin by cleaning the skin.
CA 03215163 2023- 10- 11
WO 2022/233624
PCT/EP2022/060870
4
As used herein, "compositions" with no qualifier is meant to mean the
hydratable concentrated
surfactant composition and end use composition of this invention. Hydratable,
as used herein,
means add and/or add and absorb water (i.e., to dilute) even to a composition
that has water
such as a composition that is initially 30 to 85% by weight water. Skin, as
used herein, is meant
to include skin on the arms (including underarms), face, feet, neck, chest,
hands, legs, buttocks
and scalp (including hair). Hydratable concentrated surfactant
composition ("hydratable
composition") means a lamellar composition that increases in viscosity when
water is added to
the composition to thereby produce an isotropic end use composition suitable
for topical
application. Lamellar, as used herein, means a two-dimensional phase with
lipid bilayers
separated by water layers, an opaque, hazy and/or cloudy composition having a
birefringent
pattern when viewed in an optical microscope. Isotropic means having lipid
layers of one
dimension and a transparent composition that does not display a birefringent
pattern when viewed
in an optical microscope. Transforming from a lamellar to an isotropic phase
is also confirmed
by visual examination of the concentrate becoming a transparent end use
composition after the
hydratable composition is hydrated. The hydratable composition is one which is
suitable to
optionally have a viscosity from 500 to 1,500 cps. (1 Pa-s is equal to 1000
cps). The end use
composition is one suitable to be wiped or washed off, and preferably, washed
off with water. The
end use composition can be a home care cleaning composition but is preferably
a shampoo,
make-up wash, facial wash, hand wash or personal care liquid body wash. In an
embodiment of
the invention, the end use composition can optionally have a viscosity from
6,000 to 12,000 cps
when a body wash and from 2,000 to 5,000 cps when a hand wash. The end use
composition
may, optionally, comprise medicinal or therapeutic agents, but preferably, is
a wash which is
cosmetic and non-therapeutic such that the wash removes water soluble and
water insoluble
soils. In one embodiment of the invention, the end use composition is a home
care composition
like a table-top or toilet cleaning composition. In another embodiment, the
end use composition
is a shampoo composition. In still another embodiment, the end use composition
is a personal
wash composition, and therefore, a liquid body wash. As hereinafter described,
the end use
composition of the present invention may optionally comprise skin benefit
ingredients added
thereto such as emollients, vitamins and/or derivatives thereof, resorcinols,
retinoic acid
precursors, colorants, moisturizers, sunscreens, mixtures thereof or the like.
The skin benefit
ingredients (or agents) may be water or oil soluble. If used, oil soluble skin
benefit agents typically
make up to 1.5% by weight of the hydratable composition whereby water soluble
skin benefit
agents, when used, typically make up to 10% by weight of the hydratable
composition of the
present invention. The hydratable composition and end use composition
typically have a pH from
3.5 to 10. Viscosity, unless noted otherwise, is taken with a Discovery HR-2
Rheometer using
CA 03215163 2023- 10- 11
WO 2022/233624
PCT/EP2022/060870
sand blasted plates with a 100 micron gap and a shear rate of 4-15 s-1.
Viscosity is measured at
25 C. Increase in viscosity means the hydratable composition of the present
invention will have
a starting viscosity that is lower than the final viscosity after water is
added and the resulting end
use composition is made. The end use composition is made by combining water
and hydratable
5 composition and mixing (with moderate shear like stirring, preferably
shaking) the same to
produce the end use composition having a higher viscosity than the hydratable
concentrate it is
made from. In another embodiment, the hydratable composition may be applied
directly to, for
example, skin of a consumer and when water and shear are applied (like, for
example, shearing
with the hand and water from a sink or shower) the desired end use composition
may be made.
As used herein, "substantially free of sulfate" means less than 6.0% by weight
of the end use
composition, and "substantially free of oil" means less than 0.3% by weight of
the end use
composition. Substantially free of isethionate means the anionic surfactant
has less than
0.0075% by weight isethionate, and preferably, less than 0.0050% by weight
isethionate, and
most preferably, 0.0% by weight (i.e., no isethionate) based on total weight
of the anionic
surfactant in the hydratable composition. Structuring agent means suitable to
build viscosity in a
hydrated composition substantially free of isethionate. Lamellar phase agent
means the agent
that induces lipid bilayer formation separated by water layers. The term
comprising is meant to
encompass the terms consisting essentially of and consisting of. For the
avoidance of doubt, and
for illustration, the end use composition of this invention comprising
surfactant, water and active
is meant to include a composition consisting essentially of the same and a
composition consisting
of the same. All ranges defined are meant to include all ranges subsumed
therein. Except in the
operating comparative examples, or where otherwise explicitly indicated, all
numbers in this
description indicating amounts or ratios of materials or conditions and/or
physical properties of
materials and/or use are to be understood as modified by the word "about".
Detailed Description of the Invention
As to the anionic surfactant, the same typically makes up from 1.0 to 30% by
weight of the
hydratable composition. In an embodiment of the invention, the anionic
surfactant makes up from
2.0 to 25% by weight, and preferably, from to 3.0 to 20% by weight, and most
preferably, from 6
to 15% by weight of the hydratable composition. Still in another embodiment,
anionic surfactant
makes up from 7 to 14% by weight of the hydratable composition. In another
embodiment, the
anionic surfactant is 5 to 100%, and preferably, from 30 to 100%, and most
preferably, from 35
to 100% by weight taurate and/or glycinate, based on total weight of anionic
surfactant used in
the compositions. In still another embodiment, anionic surfactant is 100%
taurate, glycinate or a
mixture of both.
CA 03215163 2023- 10- 11
WO 2022/233624
PCT/EP2022/060870
6
As to the amphoteric and/or zwitterionic surfactant used in the hydratable
composition, the
same typically makes up from 1.0 to 45%, and preferably, from 2.0 to 35%, and
most
preferably, from 12 to 25% by weight of the hydratable composition.
To, for example, aid in hydratable composition lamellar phase stabilization
and hydration, a
lamellar phase agent like C6 -C14 acid, amide and/or alcohol is preferably
used and typically
makes up from 1.0 to 16%, and preferably, from 1.8 to 12%, and most
preferably, from 3 to 8%
by weight of the hydratable concentrated composition. The preferred agent for
use is myristic
acid, lauric acid and any alcohol or amide derivatives thereof. In a most
preferred embodiment,
the lamellar phase agent used is lauric acid. In yet another preferred
embodiment, the lamellar
phase agent makes up from 4.2 to 5.2% by weight of the hydratable concentrated
composition.
Inorganic salt is an optional but often desired ingredient to aid in
composition stabilization.
Typical salts may be used like NaCI, KCI, MgCl2, CaCl2, mixtures thereof or
the like. Typically,
the inorganic salt makes up from 0 to 15%, and preferably, from 1 to 12%, and
most preferably,
from 0.75 to 4.5% by weight of the hydratable concentrated composition. In an
embodiment of
the invention, salt makes up from 2.5 to 3.5% by weight of the hydratable
concentrated
composition.
Structurants, often polymeric viscosity aids, are a desired ingredient in the
hydratable
composition of the present invention. Illustrative examples of the
structurants suitable for use in
the invention include esters of polyalkoxylated polyols and fatty acids.
Examples of such
structurants include PEG 18 glyceryloleate/cocoate, polyethylene glycol 6000
distearate, INC!
name of PEG-150 distearate; PEG 120 methyl glucose dioleate and PEG 120
methylglucose
trioleate (GlucomateTM DOE-120 and GlucomateTM VLT made available by
Lubrizol); PEG-150
Pentaerythrityl Tetrastearate (CrothixTM, CrothixTM Liquid, and VersathixTM
made available by
Croda); PEG-150 Polyglycery1-2 Tristerate (Genapol LT made available by
Clariant);
PEG/PPG-120/10-Trimethlolpropane Trioleate (Arlypone TT made available by
BASF). The
number of hydrophilic polyalkoxylated arms are two for PEG-150 distearate,
three for Arlypone
TT, four for Genapole LT and CrothixTM, CrothixTM Liquid, and VersathixTM, and
five for
GlucomateTM DOE-120.
The preferred structurants (classified as high molecular weight ethoxylated
fatty acid esters) are
PEG 120 methyl glucose dioleate, as well as PEG 150 pentaerythrityl
tetrastearate. The
structurants used make up from 0.1 to 1.2%, and preferably, from 0.2 to 1.0%,
and most
CA 03215163 2023- 10- 11
WO 2022/233624
PCT/EP2022/060870
7
preferably, from 0.25 to 0.8% by weight of the hydratable composition. In an
embodiment of the
invention, the structurant makes up from 0.35 to 0.65% by weight of the
hydratable composition.
In another embodiment of the invention, less than 3.0% by weight sulfate is
present in the end
use composition of the present invention, preferably less than 1.0% by weight,
and most
preferably, no (0.0% by weight) sulfate. In the present invention, the
hydratable composition
should be formulated such that upon dilution, the desired component/ingredient
levels (such as
sulfate levels) in the end use composition are attained.
As to anionic surfactants suitable for use in the hydratable concentrated
surfactant composition
and end use composition of the present invention, the anionic surfactant used
can include
aliphatic sulfonates, such as a primary alkane (e.g., C8-C22) sulfonate,
primary alkane (e.g., C8-
C22) disulfonate, C8-C22 alkene sulfonate, C8-C22 hydroxyalkane sulfonate or
alkyl glyceryl ether
sulfonate (AGS); or aromatic sulfonates such as alkyl benzene sulfonate. The
anionic can also
include some alkyl sulfate (e.g., C12-C18 alkyl sulfate) or alkyl ether
sulfate (including alkyl
glyceryl ether sulfates). Among the alkyl ether sulfates are those having the
formula:
RO(CH2CH20),1S03M
wherein R is an alkyl or alkenyl having 8 to 18 carbons, preferably 12 to 18
carbons, n has an
average value of at least 1.0, preferably less than 5, and most preferably 1
to 4, and M is a
solubilizing cation such as sodium, potassium, ammonium or substituted
ammonium. As noted,
sulfates, when used, make up less than 6.0% by weight of the end use
composition.
The anionic may also include alkyl sulfosuccinates (including mono- and
dialkyl, e.g., C6-C22
sulfosuccinates); alkyl and acyl taurates (often methyl taurates), alkyl and
acyl sarcosinates,
sulfoacetates, C8-C22 alkyl phosphates and phosphonates, alkyl phosphate
esters and alkoxyl
alkyl phosphate esters, acyl lactates, C8-C22 monoalkyl succinates and
maleates,
sulphoacetates, alkyl glucosides and acyl isethionates, and the like.
Sulfosuccinates may be monoalkyl sulfosuccinates having the formula:
R102CCH2CH(S03M)CO2M;
and amide-MEA sulfosuccinates of the formula:
CA 03215163 2023- 10- 11
WO 2022/233624
PCT/EP2022/060870
8
R1CONHCH2CH202CCH2CH(S03M)CO2M wherein R1 ranges from C8-C22 alkyl.
Sarcosinates are generally indicated by the formula:
R2CON(CH3)CH2CO2M, wherein R2 ranges from C8-C20 alkyl.
Taurates are generally identified by formula:
R3CONR4CH2CH2S03M
wherein R3 is a C8-C20 alkyl, R4 is a Ci-C4 alkyl.
M is a solubilizing cation as previously described.
Less than 0.0075% weight of the total weight of anionic used in the hydratable
composition
should be isethionate. If used, the isethionates may include C8-C18 acyl
isethionates (including
those which have a substituted head group such as a C1_4 alkyl substitution,
preferably methyl
substitution). These esters are prepared by a reaction between alkali metal
isethionate with
mixed aliphatic fatty acids having from 6 to 18 carbon atoms and an iodine
value of less than
20. Often at least 75% of the mixed fatty acids have from 12 to 18 carbon
atoms and up to 25%
have from 6 to 10 carbon atoms.
The small amount of acyl isethionate that may optionally be used can be an
alkoxylated
isethionate such as is described in Ilardi et al., U.S. Pat. No. 5,393,466,
entitled "Fatty Acid
Esters of Polyalkoxylated isethonic acid; issued Feb. 28, 1995; hereby
incorporated by
reference. This compound has the general formula:
R5C-0(0)--C(X)H¨C(Y)H--(OCH2--CH2)m--S03M
wherein R5 is an alkyl group having 8 to 18 carbons, m is an integer from 1 to
4, X and Y are
each independently hydrogen or an alkyl group having 1 to 4 carbons and M is a
solubilizing
cation as previously described. Preferably, the hydratable concentrated
composition is
substantially free of isethionate.
In an embodiment of the invention, the anionic surfactant used is sodium
lauroyl glycinate,
sodium cocoyl glycinate, sodium lauroyl glutamate, sodium cocoyl glutamate,
sodium methyl
lauroyl taurate, sodium methyl cocoyl taurate or a mixture thereof. Such
anionic surfactants are
CA 03215163 2023- 10- 11
WO 2022/233624
PCT/EP2022/060870
9
commercially available from suppliers like Galaxy Surfactants, Clariant, Sino
Lion and Innospec.
Sodium methyl lauroyl taurate, sodium lauroyl glycinate or mixtures thereof
are the preferred
anionics used in this invention.
Amphoteric surfactants suitable for use in the invention (which depending on
pH can be
zwitterionic) include sodium acyl amphoacetates, sodium acyl amphopropionates,
disodium acyl
amphodiacetates and disodium acyl amphodipropionates where the acyl (i.e.,
alkanoyl group)
can comprise a 07-018 alkyl portion. Illustrative examples of the amphoteric
surfactants suitable
for use include sodium lauroamphoacetate, sodium cocoamphoacetate and mixtures
thereof. If
present such surfactants make up from 0.01 to 5% and preferably, from 0.1 to
2.5% by weight
of the hydratable composition.
As to the zwitterionic surfactants that may be employed in the present
invention, such
surfactants include at least one acid group. Such an acid group may be a
carboxylic or a
sulphonic acid group. They often include quaternary nitrogen, and therefore,
can be quaternary
amino acids. They should generally include an alkyl or alkenyl group of 7 to
18 carbon atoms
generally comply with an overall structural formula:
R6-4--C(0)--NH(CH2)q--],--1\1+--(R7--)(R8)A--B where R6 is alkyl or alkenyl of
7 to 18 carbon
atoms; R7 and R8 are each independently alkyl, hydroxyalkyl or carboxyalkyl of
1 to 3 carbon
atoms; q is 2 to 4; r is 0 to 1; A is alkylene of 1 to 3 carbon atoms
optionally substituted with
hydroxyl, and B is --0O2-- or --S03--.
Suitable zwitterionic surfactants for use in the present invention and within
the above general
formula include simple betaines of formula:
R6--1\1+--(R7)(R8)CH2CO2-
and amido betaines of formula:
R6--CONH(CH2)t--N1+--(R7)(R8)CH2CO2- where t is 2 or 3.
In both formulae R6, R7 and R8 are as defined previously. R6 may, in
particular, be a mixture of
C12 and C14 alkyl groups derived from coconut oil so that at least half,
preferably at least three
quarters of the groups R6 have 10 to 14 carbon atoms. R7 and R8 are preferably
methyl.
A further possibility is that the zwitterionic surfactant is a sulphobetaine
of the formula:
CA 03215163 2023- 10- 11
WO 2022/233624
PCT/EP2022/060870
R6--kr--(R7)(R8)(CH2)3S03-
or
R6--CONH(CH2)u --N-E--(R7)(R8)(CH2)3S03-
where u is 2 or 3, or variants of these in which --(CH2)3S03- is replaced by --
5 CH2C(OH)(H)CH2S03-_
In these formulae, R6, R7 and R8 are as previously defined.
Illustrative examples of the zwitterionic surfactants suitable for use include
betaines like
cocodimethyl carboxymethyl betaine, cocamidopropyl betaine and
laurylamidopropyl betaine.
10 An additional zwitterionic surfactant suitable for use includes
cocamidopropyl sultaine. Such
surfactants are made commercially available from suppliers like Stepan
Company, and it is
within the scope of the invention to employ mixtures of the aforementioned
surfactants. In a
preferred embodiment, the zwitterionic surfactant used in the compositions of
this invention is
cocamidopropyl betaine.
Zwitterionic surfactants are preferably used and make up from 2 to 28%, and
preferably, from 6
to 25%, and most preferably, from 12 to 22% by weight of the hydratable
composition. In an
embodiment of the invention, zwitterionic surfactant makes up from 16 to 21%
by weight of the
hydratable concentrate.
Nonionic surfactants may optionally be used in the hydratable composition and
end use
composition of the present invention. When used, nonionic surfactants are
typically used at
levels as low as 0.5, 1, 1.5 or 2% by weight and at levels as high as 6, 8, 10
or 12% by weight
of the end use composition. The nonionics which may be used include in
particular the reaction
products of compounds having a hydrophobic group and a reactive hydrogen atom,
for example
aliphatic alcohols, acids, amides or alkylphenols with alkylene oxides,
especially ethylene oxide
either alone or with propylene oxide. Specific nonionic surfactant compounds
are alkyl (C6-022)
phenols ethylene oxide condensates, the condensation products of aliphatic (Cs-
CIO primary or
secondary linear or branched alcohols with ethylene oxide, and products made
by condensation
of ethylene oxide with the reaction products of propylene oxide and
ethylenediamine. Other
nonionic surfactants include long chain tertiary amine oxides, long chain
tertiary phosphine
oxides, dialkyl sulphoxides, and the like.
CA 03215163 2023- 10- 11
WO 2022/233624
PCT/EP2022/060870
11
In an embodiment of the invention, nonionic surfactants optionally used can
include fatty
acid/alcohol ethoxylates having the following structures a)
HOCH2(CH2)s(CH2CH20)õ H or b)
HOOC(CH2),(CH2CH20)d H; where s and v are each independently an integer up
to18; and c
and d are each independently an integer from 1 or greater. In an embodiment of
the invention, s
and v are each independently 6 to 18; c and d are each independently 1 to 30.
Other options for
nonionic surfactants include those having the formula HOOC(CH2);-CH=CH--
(CH2)k(CH2CH20),
H, where i, k are each independently 5 to 15; and z is 5 to 50. In another
embodiment of the
invention, i and k are each independently 6 to 12; and z is 15 to 35.
The nonionic may also include a sugar amide, such as a polysaccharide amide.
Specifically, the
surfactant may be one of the lactobionamides described in U.S. Pat. No.
5,389,279 to Au et al.,
entitled "Compositions Comprising Nonionic Glycolipid Surfactants issued Feb.
14, 1995; which
is hereby incorporated by reference or it may be one of the sugar amides
described in U.S. Pat.
No. 5,009,814 to Kelkenberg, titled Use of N-Poly Hydroxyalkyl Fatty Acid
Amides as
Thickening Agents for Liquid Aqueous Surfactant Systems" issued Apr. 23, 1991;
hereby
incorporated into the subject application by reference.
In an embodiment of the invention, cationic surfactants may optionally be used
in the hyd ratable
composition and end use composition of the present invention.
One class of optional cationic surfactants includes heterocyclic ammonium
salts such as cetyl
or stearyl pyridinium chloride, alkyl amidoethyl pyrrylinodium methyl sulfate,
and lapyrium
chloride.
Tetra alkyl ammonium salts are another useful class of cationic surfactants
suitable for optional
use. Examples include cetyl or stearyl trimethyl ammonium chloride or bromide;
hydrogenated
palm or tallow trimethylammonium halides; behenyl trimethyl ammonium halides
or methyl
sulfates; decyl isononyl dimethyl ammonium halides; ditallow (or distearyl)
dimethyl ammonium
halides, and behenyl dimethyl ammonium chloride.
Still other types of cationic surfactants that may be used are the various
ethoxylated quaternary
amines and ester quats. Examples include PEG-5 stearyl ammonium lactate (e.g.,
Genamin
KSL manufactured by Clariant), PEG-2 coca ammonium chloride, PEG-15
hydrogenated tallow
ammonium chloride, PEG 15 stearyl ammonium chloride, dipalmitoyl ethyl methyl
ammonium
CA 03215163 2023- 10- 11
WO 2022/233624
PCT/EP2022/060870
12
chloride, dipalmitoyl hydroxyethyl methyl sulfate, and strearyl amidopropyl
dimethylamine
lactate.
Even other useful cationic surfactants suitable for optional use include
quaternized hydrolysates
of silk, wheat, and keratin proteins, and it is within the scope of the
invention to use mixtures of
the aforementioned cationic surfactants.
If used, cationic surfactants will make up no more than 1.0% by weight of the
hydratable
composition. When present, they typically make up from 0.01 to 0.7%, and more
typically, from
0.1 to 0.5% by weight of the end use composition, including all ranges
subsumed therein.
In an embodiment of this invention, the end use composition of this invention
will be
substantially free of polymeric quaternary ammonium compounds (including salts
of the same).
In another embodiment, the end use composition will comprise less than 0.1% by
weight
polymeric quaternary ammonium compounds. In yet another embodiment, the end
use
composition comprises less than 0.01% by weight polymeric quaternary ammonium
compounds. In even another embodiment, the hydratable composition and end use
composition
are free of polymeric quaternary ammonium compounds (i.e., 0.0%).
Water makes up from 30 to 85%, typically, from 30 to 78%, and preferably, from
35 to 75% by
weight of the hydratable composition, and most preferably, from 40 to 70% by
weight of the
hydratable composition.
The pH of the hydratable composition and end use composition is typically from
3.5 to 10, and
preferably, from 4.5 to 9, and most preferably, from 4.7 to 7.5, including all
ranges subsumed
therein. Adjusters suitable to modify/buffer the pH may be used. Such pH
adjusters include
triethylamine, NaOH, KOH, H2SO4, HCI, 08 H8 07 (i.e., citric acid) or mixtures
thereof. The pH
adjusters are added at amounts to yield the desired final pH. The pH values
may be assessed
with commercial instrumentation such as a pH meter made commercially available
from Thermo
Scientific . In an embodiment of the invention, the pH of the end use
composition is 4.8 to 7,
and in another embodiment from 4.9 to 6.
Optional skin benefit agents suitable for use in this invention are limited
only to the extent that
they are capable of being topically applied, and suitable to dissolve in the
hydratable
composition and end use composition at the desired pH.
CA 03215163 2023- 10- 11
WO 2022/233624
PCT/EP2022/060870
13
Illustrative examples of the benefit agents suitable to include in the water
portion of the
compositions are vitamin B2, niacinamide (vitamin B3), vitamin B6, vitamin C,
mixtures thereof or
the like. Water soluble derivatives of such vitamins may also be employed. For
instance, vitamin
C derivatives such as ascorbyl tetraisopalmitate, magnesium ascorbyl phosphate
and ascorbyl
glycoside may be used alone or in combination with each other. Other water
soluble benefit
agents suitable for use include 4-ethyl resorcinol, extracts like sage, aloe
vera, green tea,
grapeseed, thyme, chamomile, yarrow, cucumber, liquorice, rosemary extract or
mixtures
thereof. Water soluble sunscreens like ensulizole may also be used. Total
amount of optional
water soluble benefit agents (including mixtures) when present in the
invention may range from
0.0 to 10%, preferably from 0.001 to 8%, and most preferably, from 0.01 to 6%
by weight,
based on total weight of the end use composition.
It is also within the scope of the present invention to optionally include oil
(i.e., non-water)
soluble benefit agents. The end use composition is substantially free of oil,
and preferably, has
less than 0.15% by weight oil, and most preferably, no oil (0.0%) where oil is
not meant to
include any oil from a fragrance. Thus, oil soluble actives or benefit agents
are solubilized in the
surfactants used. The only limitation with respect to such oil soluble benefit
agents are that the
same are suitable to provide a benefit when topically applied. The composition
has preferably
less than 0.15% petrolatum (petroleum jelly), more preferably is free from
petrolatum.
Illustrative examples of the types of oil soluble benefit agents that may
optionally be used in the
compositions of this invention include components like stearic acid, vitamins
like Vitamin A, D, E
and K (and their oil soluble derivatives), sunscreens like
ethylhexylmethoxycinnamate, bis-ethyl
hexyloxyphenol methoxyphenol triazine, 2-ethylhexy1-2-cyano-3,3-dipheny1-2-
propanoic acid,
drometrizole trisiloxane, 3,3,5-trimethyl cyclohexyl 2-hydroxybenzoate, 2-
ethylhexy1-2-
hydroxybenzoate or mixtures thereof.
Other optional oil soluble benefit agents suitable for use include resorcinols
like 4-hexyl
resorcinol, 4-phenylethyl resorcinol, 4-cyclopentyl resorcinol, 4-cyclohexyl
resorcinol 4-isopropyl
resorcinol or a mixture thereof. Also, 5-substituted resorcinols like 4-
cyclohexy1-5-
methylbenzene-1,3-diol, 4-isopropyl-5-methylbenzene-1,3-diol, mixtures thereof
or the like may
be used. The 5-substituted resorcinols, and their synthesis are described in
commonly
assigned U.S. Published Patent Application No. 2016/0000669A1.
CA 03215163 2023- 10- 11
WO 2022/233624
PCT/EP2022/060870
14
Even other oil soluble actives suitable for use include omega-3 fatty acids,
omega-6 fatty acids,
climbazole, farnesol, ursolic acid, myristic acid, geranyl geraniol, leyl
betaine, cocoyl
hydroxyethyl imidazoline, hexanoyl sphingosine, 12-hydroxystearic acid,
petroselinic acid,
conjugated linoleic acid, terpineol, thymol mixtures thereof or the like.
In an embodiment of the invention, the optional oil soluble benefit agent used
is a retinoic acid
precursor. In one embodiment of the invention, the retinoic acid precursor is
retinol, retinal,
retinyl propionate, retinyl palmitate, retinyl acetate or a mixture thereof.
Retinyl propionate,
retinyl palmitate and mixtures thereof are typically preferred. Additionally,
12-hydroxystearic
acid is often preferred for use.
When optional oil soluble active is used in the compositions of the invention,
it typically makes
up from 0.0 to 1.5%, and preferably, from 0.001 to 1.5%, and most preferably,
from 0.05 to
1.2% by weight of the end use composition. In yet another embodiment, oil
makes up from 0.1
to 0.5% by weight of the total weight of the end use composition.
Preservatives can desirably be incorporated into the hydratable concentrated
surfactant
composition and end use composition to protect against the growth of
potentially harmful
microorganisms. Cosmetic chemists are familiar with appropriate preservatives
and routinely
choose them to satisfy the preservative challenge test and to provide product
stability. Suitable
traditional preservatives for use include hydantoin derivatives and propionate
salts. Particularly
preferred preservatives are iodopropynyl butyl carbamate, phenoxyethanol,
sodium benzoate,
hydroxyacetophenone, ethylhexylglycerine, hexylene glycol, methyl paraben,
propyl paraben,
imidazolidinyl urea, sodium dehydroacetate, dimethyl-dimethyl (DMDM) hydantoin
and benzyl
alcohol and mixtures thereof. Other preservatives suitable for use include
sodium
dehydroacetate, chlorophenesin and decylene glycol. The preservatives should
be selected
having regard for the use of the composition and possible incompatibilities
between the
preservatives and other ingredients in the emulsion. Preservatives are
preferably employed in
amounts ranging from 0.01% to 2.0% by weight of the total weight of the end
use composition
(up to 7% by weight of total hydratable concentrated surfactant composition),
including all
ranges subsumed therein. Also preferred is a preservative system with
hydroxyacetophenone
alone or in a mixture with other preservatives. Standard emollients, like
vicinal diols (e.g., 1,2-
hexane diol and/or 1,2-octane diol) may be used with the preservatives. In an
embodiment of
the invention, the preservative used is sodium benzoate when the pH of the
compositions is 7
or under, and preferably, 6 or under.
CA 03215163 2023- 10- 11
WO 2022/233624
PCT/EP2022/060870
Thickening agents are optionally suitable for use in the compositions of the
present invention.
Particularly useful are the polysaccharides. Examples include fibers,
starches, natural/synthetic
gums and cellulosics. Representative of the starches are chemically modified
starches such as
5 sodium hydroxypropyl starch phosphate and aluminum starch
octenylsuccinate. Tapioca starch
is often preferred, as is maltodextrin. Suitable gums include xanthan,
sclerotium, pectin, karaya,
arabic, agar, guar (including Acacia senegal guar), carrageenan, alginate and
combinations
thereof. Suitable cellulosics include hydroxypropyl cellulose, hydroxypropyl
methylcellulose,
ethylcellulose, sodium carboxy methylcellulose (cellulose gum/carboxymethyl
cellulose) and
10 cellulose (e.g. cellulose microfibrils, cellulose nanocrystals or
microcrystalline cellulose).
Sources of cellulose microfibrils include secondary cell wall materials (e.g.
wood pulp, cotton),
bacterial cellulose, and primary cell wall materials. Preferably the source of
primary cell wall
material is selected from parenchymal tissue from fruits, roots, bulbs,
tubers, seeds, leaves and
combination thereof; more preferably is selected from citrus fruit, tomato
fruit, peach fruit,
15 pumpkin fruit, kiwi fruit, apple fruit, mango fruit, sugar beet, beet
root, turnip, parsnip, maize,
oat, wheat, peas and combinations thereof; and even more preferably is
selected from citrus
fruit, tomato fruit and combinations thereof. A most preferred source of
primary cell wall material
is parenchymal tissue from citrus fruit. Citrus fibers, such as those made
available by
Herbace10 as AQ Plus can also be used as source for cellulose microfibrils.
The cellulose
sources can be surface modified by any of the known methods including those
described in
Colloidal Polymer Science, Kalia et al., "Nanofibrillated cellulose: surface
modification and
potential applications" (2014), Vol 292, Pages 5-31.
Synthetic polymers, in addition to structurants, are yet another class of
thickening agents that
can optionally be used. This category includes crosslinked polyacrylates such
as the
Carbomers, polyacrylamides such as Sepigel 305 and taurate copolymers such as
Simulgel
EG and Aristoflex AVC, the copolymers being identified by respective INCI
nomenclature as
Sodium Acrylate/Sodium Acryloyldimethyl Taurate and Acryloyl
Dimethyltaurate/Vinyl
Pyrrolidone Copolymer. Another preferred synthetic polymer suitable for
thickening is an
acrylate-based polymer made commercially available by Seppic and sold under
the name
Simulgel INS100. Calcium carbonate, fumed silica, and magnesium-aluminum-
silicate may also
be used.
CA 03215163 2023- 10- 11
WO 2022/233624
PCT/EP2022/060870
16
The amounts of optional thickening agent, when used, may range from 0.001 to
5%, by weight
of the compositions. Maltodextrin, xanthan gum, and carboxymethyl cellulose
are the often
preferred optional thickening agents.
In an embodiment of the invention and given the compositions of the present
invention are
substantially free of isethionates, the pH of the compositions are in the
acidic range, and
therefore, no higher than 7, and preferably, no higher than 6. In such
compositions, the desired
preservative is sodium benzoate and the end use composition is formulated with
from 0.01 to
4%, and preferably, from 0.05 to 1.5%, and most preferably, from 0.05 to 0.6%
by weight of an
acidic active or skin benefit agent. Often preferred acidic actives include
alpha hydroxy acids
like citric acid, glycolic acid, lactic acid, malic acid, tartaric acid or
mixtures thereof. Beta
hydroxy acids are also suitable for use and these include
salicylic acid, salicylate, sodium salicylate, willow, beta hydroxybutanoic
acid, tropic acid
trethocanic acid or mixtures thereof. Amino acids are also desirable for use
and these include
arginine, valine and/or histidine.
Fragrances, fixatives, chelators (like EDTA) and exfoliants may optionally be
included in the
compositions of the present invention. Each of these substances may range from
about 0.03 to
about 5%, preferably between 0.1 and 3% by weight of the total weight of the
end use
composition, including all ranges subsumed therein. To the extent the
exfoliants are used, those
selected should be of small enough particle size so that they do not impede
the performance of
any packaging used to dispense the compositions of this invention.
Conventional emulsifiers having an HLB of greater than 8 may optionally be
used. Illustrative
examples include Tween, 40, 60, 80, polysorbate 20 and mixtures thereof.
Typically, emulsifiers
for water continuous systems make up from 0.3 to 2.5% by weight of the end use
composition.
Conventional humectants may optionally be employed as additives in the present
invention to
assist in moisturizing skin when such end use compositions (i.e., emulsions)
are topically
applied. These are generally polyhydric alcohol type materials. Typical
polyhydric alcohols
include glycerol (i.e., glycerine or glycerin), propylene glycol, dipropylene
glycol, polypropylene
glycol (e.g., PPG-9), polyethylene glycol, sorbitol, hydroxypropyl sorbitol,
hexylene glycol, 1,3-
butylene glycol, isoprene glycol, 1,2,6-hexanetriol, ethoxylated glycerol,
propoxylated glycerol
and mixtures thereof. Most preferred is glycerin, propylene glycol or a
mixture thereof. The
amount of humectant employed may range anywhere from 0.0 to 15% by weight of
the total
CA 03215163 2023- 10- 11
WO 2022/233624
PCT/EP2022/060870
17
weight of the compositions. Often, humectant makes up from 0.1 to 10%, and
preferably, from
0.1 to 2.5% by weight (most preferably, from 0.2 to 1.5% by weight) of the
total weight of the
end use composition.
As to the end use compositions of the present invention, the same typically
have from 1 to 35%,
and preferably, from 2 to 30%, and most preferably, from 3 to 16% by weight
total surfactant,
based on total weight of the end use composition and including all ranges
subsumed therein. In
an embodiment of the invention, the end use composition comprises from 7 to
10% by weight
total surfactant based on total weight of the end use composition and
including all ranges
subsumed therein.
The present invention is directed to hydratable concentrated surfactant
composition that
thickens and thus displays an increase in viscosity when mixed and diluted
with water. In an
embodiment of the invention, when the weight percent of zwitterionic
surfactant to the weight
percent of anionic surfactant exceeds 3:1 in the compositions, structuring
agent (e.g., lauric
acid) should be present at over 15% by weight of the total weight of
surfactant in the
compositions. Additionally, and in another embodiment of the invention, when
the zwitterionic
surfactant to anionic surfactant weight ratio is less than 1.5, structuring
agent makes up 27% by
weight or less of the total weight of surfactant in the compositions. In
another embodiment,
when the weight percent of zwitterionic surfactant to the weight percent of
anionic surfactant
exceeds 3:1 in the compositions, structuring agent (e.g., lauric acid) should
be present at over
15% by weight of the total weight of surfactant in the compositions and when
the zwitterionic
surfactant to anionic surfactant weight ratio is less than 1.5, structuring
agent makes up 27% by
weight or less than the total weight of surfactant in the compositions.
When making hydratable composition of the present invention, the desired
ingredients may be
mixed with conventional apparatus under moderate shear and atmospheric
conditions, with
temperature being from 35 to 80 C. Water is added to the hydratable
composition to produce
the end use composition. Moderate shear such as shaking (or stirring) in a
container will yield
the end use composition in less than 5 minutes, preferably in less than 3
minutes, and most
preferably, in less than 2 minutes. In an embodiment of the invention, end use
composition is
made in less than 1 minute, even preferably, less than 30 seconds. The end use
composition
will typically comprise 65 to 95%, and preferably, from 65 to 90%, and most
preferably, from 65
to 88% by weight water based on total weight of the end use composition. In an
embodiment of
CA 03215163 2023- 10- 11
WO 2022/233624
PCT/EP2022/060870
18
the invention, water makes up from 68 to 85% by weight of the end use
composition, and in
another embodiment, 72 to 80% by weight of the end use composition.
Accordingly, the present invention relates in a further aspect to a method to
prepare an end use
composition, the method comprising the step of diluting a hydratable
composition of the present
invention with water. Preferably, the composition is diluted at a composition
to water weight
ratio from 1:1 to 1:10. The hydratable concentrated surfactant composition has
a viscosity from
25 to 10,000 cps and upon dilution the viscosity increases resulting in an end
use composition
having a viscosity from 1,000 to 20,000 cps, The viscosity is measured with a
Discovery HR-2
Rheometer using sand blasted plates with a 100 micron gap and a shear rate of
4-15 s-1 and at
a temperature of 25 C.
The packaging for the compositions typically is not limited as long as
hydratable composition
can be hydrated and end use composition can be made upon the addition of
water. In an
embodiment on the invention, the hydratable composition is sold in a pouch
(including polyvinyl
alcohol sachet) or cartridge that is associated with and inserted in a bottle
or canister. The
bottle or canister is one which is filled with water and allows for the
release of the hydratable
composition into the same for mixing with water. Typically, the bottle or
canister has a cap with
a pump that opens the sachet or canister to release the hydratable composition
into the water to
make end use composition. Such a hydratable composition unexpectedly yields an
end use
composition, such as a body wash, with desirable characteristics appreciated
by consumers.
The packaging allows for infinite numbers of refilling to invariably reduce
plastic waste in the
environment.
The hydratable concentrated composition is preferably packaged in a refill
packaging.
Preferably, the hydratable concentrated composition is used as a refill-
composition. Packaging
that includes post consumer resin is often preferred.
The Examples provided are to facilitate an understanding of the invention.
They are not
intended to limit the scope of the claims.
CA 03215163 2023- 10- 11
WO 2022/233624
PCT/EP2022/060870
19
Example I
Illustrative hydratable concentrated surfactant compositions consistent with
this invention and
assessed in Example II were prepared by combining the ingredients identified
below.
Each Sample of this Example, as set forth in the Tables, were made by
conventional means,
and therefore, by mixing ingredients with moderate shear under atmospheric
conditions at a
temperature from about 35 to 75 C. VersathixTM is PEG 150 pentaerythritol
tetrastearate.
Sample I Sample II
Ingredient Weight Percent
Ingredient Weight Percent
DI Water 61.77 DI Water
61.77
Cocamidopropyl Betaine 14.13 Cocamidopropyl Betaine
14.13
Sodium Hydroxide 0.68 Sodium Hydroxide
0.68
Lauric Acid 4.62 Lauric Acid
4.62
Sodium Lauroyl Glycinate 0.00 Sodium Lauroyl Glycinate
2.0
Sodium Lauroyl Taurate 10.87 Sodium Lauroyl Taurate
8.87
Glycerin 0.95 Glycerin
0.95
Chelator 0.05 Chelator
0.05
Preservative 0.61 Preservative
0.61
Sodium Chloride 3.0 Sodium Chloride
3.0
VersathiXTM 0.32 Versathix
0.32
Fragrance 3.0 Fragrance
3.0
Total 100 Total
100
CA 03215163 2023- 10- 11
WO 2022/233624
PCT/EP2022/060870
Example ll
The compositions (i.e., end use/diluted compositions) in the Table were made
by hydrating the
hydratable concentrated surfactant compositions (from Example l). The
hydratable
compositions were diluted (water to composition) at a weight ratio of 2 to 1.
For the avoidance
5 of doubt, "Concentrate Viscosity" means the viscosity of hydratable
composition and "Dilute
Viscosity" means the viscosity of the end use wash composition made, both in
centipoise (cps).
Water and hydratable composition were combined in a vessel and were agitated
with mild
shaking. In less than one (1) minute, desired end use wash compositions
(transparent /isotropic
and homogeneous) were unexpectedly obtained with increased viscosities.
10 Table
Sample CAPB Glycinate Taurate Lauric NaCI Concentrate Dilute
Acid Viscosity
Viscosity
1 21.2% 2% 8.8% 4.6% 3% 1830
7742
2 21.2% 0% 10.8% 4.6% 3% 1459 6845
CAPB-cocamidopropyl betaine
Glycinate-sodium Lauroyl Glycinate
Taurate- sodium methyl lauroyl taurate
15 Versathix- PEG 150 pentaerythritol tetrastearate
As can be seen from the data provided, the end use compositions made according
to this
invention where prepared in less than one (1) minute of agitation and they
surprisingly
thickened (increased in viscosity) when combined with water. The hydratable
compositions
20 were hazy (lamellar) and the end use compositions were surprisingly
thicker yet transparent
(isotropic) after visual inspection. The transformation from a lamellar phase
to an isotropic
phase was also confirmed when the compositions were placed on a glass slide
and assessed in
an optical microscope fitted with cross-polarizers. The end use compositions
did not display a
birefringent pattern.
30
CA 03215163 2023- 10- 11
